Cargando…

Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases

Thyroid associated ophthalmopathy (TAO) is an autoimmune inflammatory disorder which disfigures appearance, threatens vision, and results in a pronounced loss of quality of life. The diversity and ethnic difference of the disease manifestations have made it difficult to tailor therapies for each pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qian, Ye, Huijing, Ding, Yungang, Chen, Guo, Liu, Zhichang, Xu, Jianan, Chen, Rongxin, Yang, Huasheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417486/ https://www.ncbi.nlm.nih.gov/pubmed/28472149 http://dx.doi.org/10.1371/journal.pone.0176064

Ejemplares similares

Metformin Attenuates Inflammation and Fibrosis in Thyroid-Associated Ophthalmopathy
por: Xu, Zhihui, et al.
Publicado: (2022)

Serelaxin Alleviates Fibrosis in Thyroid-Associated Ophthalmopathy via the Notch Pathway
por: Sun, Anqi, et al.
Publicado: (2023)

The Therapeutic Effect of Combination of Orbital Decompression Surgery and Methylprednisolone Pulse Therapy on Patients with Bilateral Dysthyroid Optic Neuropathy
por: Xu, Jianan, et al.
Publicado: (2020)

Differential Circular RNA Expression Profiling of Orbital Connective Tissue From Patients With Type I and Type II Thyroid-Associated Ophthalmopathy
por: Ye, Huijing, et al.
Publicado: (2022)

Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves’ Ophthalmopathy by Targeting Orbital Fibroblasts
por: Yang, Shenglan, et al.
Publicado: (2022)

Association of p53 rs1042522, MDM2 rs2279744, and p21 rs1801270 polymorphisms with retinoblastoma risk and invasion in a Chinese population
por: Chen, Rongxin, et al.
Publicado: (2015)

Thyroid-associated Ophthalmopathy
por: Şahlı, Esra, et al.
Publicado: (2017)

Corticosteroids in Moderate-To-Severe Graves’ Ophthalmopathy: Oral or Intravenous Therapy?
por: Penta, Laura, et al.
Publicado: (2019)

Influence of 4‐week or 12‐week glucocorticoid treatment on metabolic changes in patients with active moderate‐to‐severe thyroid‐associated ophthalmopathy
por: Chen, Xiaoman, et al.
Publicado: (2021)

Cytokines in Thyroid-Associated Ophthalmopathy
por: Zhang, Pengbo, et al.
Publicado: (2022)

Elevated Immunoglobulin G4 Levels in Patients with Thyroid Eye Disease and Their Clinical Implications
por: Ye, Huijing, et al.
Publicado: (2020)

Polyester 5–0 suture for porous implant placement after retinoblastoma enucleation: analysis of 120 sockets
por: Ye, Huijing, et al.
Publicado: (2023)

Efficacy and Safety of 6-Weekly versus 12-Weekly Intravenous Methylprednisolone in Moderate-to-Severe Active Thyroid-Associated Ophthalmopathy
por: Lai, Kenneth K. H., et al.
Publicado: (2023)

IL-11 Is Elevated and Drives the Profibrotic Phenotype Transition of Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy
por: Wu, Pengsen, et al.
Publicado: (2022)

FRI547 Orbital Surgery In Moderate-To-Severe Graves´Ophthalmopathy: Institutional Experience
por: Delfino, Laura, et al.
Publicado: (2023)

Altered Corneal Nerves in Chinese Thyroid-Associated Ophthalmopathy Patients Observed by In Vivo Confocal Microscopy
por: Wu, Lian-Qun, et al.
Publicado: (2019)

Results of diplopia and strabismus in patients with severe thyroid ophthalmopathy after orbital decompression
por: Roncevic, Radmilo, et al.
Publicado: (2014)

Are Ethnicity, Social Grade, and Social Deprivation Associated With Severity of Thyroid-Associated Ophthalmopathy?
por: Edmunds, Matthew R., et al.
Publicado: (2014)

Radiological Staging of Thyroid-Associated Ophthalmopathy: Comparison of T1 Mapping with Conventional MRI
por: Chen, Lu, et al.
Publicado: (2020)

Research progress and application of artificial intelligence in thyroid associated ophthalmopathy
por: Diao, Jiale, et al.
Publicado: (2023)

Thyroid antibody-negative euthyroid Graves’ ophthalmopathy
por: Tabasum, Arshiya, et al.
Publicado: (2016)

The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy
por: Huang, Yazhuo, et al.
Publicado: (2018)

Intraorbital Electroacupuncture Therapy for Thyroid-associated Ophthalmopathy
por: Zhou, Ling-Yun, et al.
Publicado: (2017)

Intraorbital Steroid Injection for Active Thyroid Ophthalmopathy
por: Bagheri, Abbas, et al.
Publicado: (2020)

Treating Thyroid Associated Ophthalmopathy in Pediatric Patients
por: Dong, Tianyu, et al.
Publicado: (2022)

A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy
por: Wang, Yang, et al.
Publicado: (2018)

Disrupted Topological Organization of the Brain Structural Network in Patients With Thyroid-Associated Ophthalmopathy
por: Wu, Qian, et al.
Publicado: (2021)

Altered dynamic brain activity and functional connectivity in thyroid‐associated ophthalmopathy
por: Jiang, Wen‐Hao, et al.
Publicado: (2023)

Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated Ophthalmopathy
por: Tu, Yunhai, et al.
Publicado: (2016)

Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy
por: McCorquodale, Tom, et al.
Publicado: (2012)

PTX3: A Potential Biomarker in Thyroid Associated Ophthalmopathy
por: Mou, Pei, et al.
Publicado: (2018)

Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy
por: Choi, Seung Woo, et al.
Publicado: (2016)

Outcome of thyroid associated ophthalmopathy treated by radiation therapy
por: Abboud, Mirna, et al.
Publicado: (2011)

Diagnosis, Follow-Up and Treatment Results in Thyroid Ophthalmopathy
por: Savku, Esra, et al.
Publicado: (2015)

Cutting‐edge endonasal surgical approaches to thyroid ophthalmopathy
por: Tyler, Matthew A., et al.
Publicado: (2018)

Clinical outcomes of hypofractionated radiotherapy for thyroid-associated ophthalmopathy
por: Lee, Sang Min, et al.
Publicado: (2020)

Teprotumumab as a Novel Therapy for Thyroid-Associated Ophthalmopathy
por: Smith, Terry J.
Publicado: (2020)

Effect of teprotumumab on intraocular pressure in thyroid-associated ophthalmopathy
por: Adetunji, Modupe O., et al.
Publicado: (2022)

The significance of ophthalmological features in diagnosis of thyroid-associated ophthalmopathy
por: Huang, Xiao, et al.
Publicado: (2023)

Therapeutic outcomes of mycophenolate mofetil and glucocorticoid in thyroid-associated ophthalmopathy patients
por: Li, Lan-Fang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2neadadkk9vc2ktnk3384e57re